Haynes and Boone NY Lawyers Join Client InspireMD at NYSE Bell Ringing

10/24/2013


NEW YORK – Five Haynes and Boone, LLP lawyers joined the InspireMD leadership team in celebrating the company’s recent listing on the NYSE MKT by ringing The Opening Bell on Oct. 24.

New York Partners Rick WernerTodd Ransom and Craig Unterberg, and Associates Casey Cohn and Ariel Zell accompanied the InspireMD team led by Alan Milinazzo, president and chief executive officer, and Craig Shore, chief financial officer.

The company began trading on the NYSE MKT April 11.

Video of the occasion can be viewed by clicking here.

About InspireMD, Inc. (NYSE MKT: NSPR)
InspireMD is an emerging medical device company developing and commercializing advanced stent technology for interventional cardiology and other vascular procedures. The company seeks to utilize its proprietary MGuard technology to make its products the industry standard for embolic protection stents and to provide a superior solution to the key clinical issues of current stenting in patients with a high risk of distal embolization, no reflow and major adverse cardiac events. InspireMD intends to pursue applications of this technology in coronary, carotid and peripheral artery procedures. InspireMD’s common stock is quoted on the NYSE MKT under the ticker symbol NSPR. MGuard EPS is CE Mark approved. It is not approved for sale in the U.S. by the FDA at this time.

Media Contacts

Nathan Koppel
Director of Media Relations
+1 512.867.8431
nathan.koppel@haynesboone.com
Linda Campbell
Communications Manager
+1 214.651.5362
linda.campbell@haynesboone.com

Related Practices

Email Disclaimer